Replies to post #501123 on NorthWest Biotherapeutics Inc (NWBO)

[Fireman02360]

Journal has zero weight when going for approval with RAs. So in the end, it matters not if a journal gets published or not. Approval is coming within the next 6 months, and that in itself will move the SP in the proper direction.

-Fireman

[biosectinvestor]

They presented stellar trial data, they have outperformed many other investments over 5 and 2 years measure and YTD are flat while much of the market is severely down.

I would take their trial results over the 400+ trials that have failed in GBM and their improvement in results over any drug announced in the last 20-30 years overall for GBM, well, really ever.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169583224